Mometason Glenmark (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometason Glenmark, is a corticosteroid presented as a topical formulation for skin application. It reduces inflammation and itching associated with psoriasis, eczema, atopic dermatitis and allergic skin reactions in both adult and pediatric patients when prescribed by a healthcare professional.

GNH USA supplies Mometason Glenmark as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across global markets. The product complies with European Union pharmacopeial standards.

Mometasone furoate, a topical glucocorticoid, is used to manage inflammatory skin disorders.

- Psoriasis: diminishes plaque formation, scaling and erythema. - Eczema: alleviates redness, itching and oozing lesions. - Atopic dermatitis: controls flare‑ups, reduces skin thickening and discomfort. - Allergic skin reactions: suppresses localized immune response and relieves irritation.

Topical application of mometasone furoate may cause local skin reactions.

Common Side Effects: - Burning or stinging sensation at the application site. - Mild itching or dryness. - Erythema or mild redness. - Folliculitis or acne‑like eruptions. - Skin irritation or peeling.

Serious or Rare Side Effects: - Skin atrophy or thinning. - Hypopigmentation or depigmented patches. - Secondary bacterial, fungal or viral infection. - Systemic adrenal suppression with extensive use. - Allergic contact dermatitis or severe hypersensitivity reactions.

Before using Mometason Glenmark, consider the following safety measures.

- Assess severity: limit use to short‑term treatment of mild to moderate inflammation. - Avoid occlusion: do not cover treated area with airtight dressings unless directed. - Monitor children: use the lowest effective amount and duration in pediatric patients. - Review concomitant steroids: avoid simultaneous use of other potent corticosteroids on the same area. - Discontinue if infection develops: stop treatment and seek medical advice for signs of bacterial or fungal infection. - Store at room temperature: keep in the original container, protect from moisture and light.

Mometasone furoate may interact with other agents that affect corticosteroid activity or skin absorption.

Major Interactions (Avoid):\n- Systemic corticosteroids: additive immunosuppression may increase infection risk. - Potent CYP3A4 inhibitors (e.g., ketoconazole): may raise systemic exposure when large skin areas are treated. - Live vaccines: concurrent use can diminish vaccine efficacy.

Moderate Interactions (Monitor Closely): - Topical antifungals or antibiotics: may reduce each other's efficacy. - Occlusive dressings or bandages: increase percutaneous absorption, requiring dose adjustment. - Alcohol‑based cleansers: can enhance irritation when used on the same site.